RDY

#746
Dr. Reddy's Laboratories Ltd
13.6 2 USD
+0.67%
Sektor: Gesundheitswesen
Basis: USD
Gewinnwährung: USD
Tagesspanne
13.60
13.66
Jahresspanne
12.18
16.16
Tagesänderung
+0.67%
Monatliche Änderung
-1.16%
6 month change
-2.78%
Jahresänderung
-6.90%
Vorheriger Schlusskurs
13.5 3
Open
13.6 5
Tief
13.6 0
High
13.6 6
Volumen
441
Vollständige Grafik anzeigen Full chart

Financials

Übersicht Finanzbericht Statistik Dividenden
Vierteljährlich Jährlich
  • Market Capitalization 11.37 B
  • Employee 28 K
  • Founded 1984
  • CEO Erez Israeli
  • Website www.drreddys.com
  • Headquarter India
  • FIGI BBG000NJ96L6
  • Industry Arzneimittelhersteller – spezialisierte und Generika
Gesamtumsatz
Jahresüberschuss
Gesamtverschuldung
Freier Cashflow
Zahlungsmittel und Zahlungsmitteläquivalente

Dr. Reddy's Laboratories Ltd

Dr. Reddy's Laboratories Ltd. is an Indian multinational pharmaceutical company based in Hyderabad, with U.S. headquarters in East Brunswick, New Jersey. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. Dr. Reddy manufactures and markets a wide range of pharmaceuticals in India and overseas. The company produces over 190 medications, 60 active pharmaceutical ingredients for drug manufacture, diagnostic kits, critical care, and biotechnology. Dr. Reddy's began as a supplier to Indian drug manufacturers, but it soon started exporting to less-regulated markets that had the advantage of not having to spend time and money on a manufacturing plant that would gain approval from a drug licensing body such as the U.S. Food and Drug Administration. By the early 1990s, the expanded scale and profitability from these unregulated markets enabled the company to begin focusing on getting approval from drug regulators for their formulations and bulk drug manufacturing plants – in more-developed economies. This allowed their movement into regulated markets such as the US and Europe. By 2007, Dr.

Nachrichten